Rosalind Advisors, Inc. - 13 Feb 2025 SCHEDULE 13G/A Report for Trevi Therapeutics, Inc. Common Shares (TRVI)

Filing Manager
Rosalind Advisors, Inc.
Reporting Manager
Rosalind Advisors, Inc.
Security
Trevi Therapeutics, Inc. Common Shares
Symbol
TRVI
Shares outstanding
88,541,667 shares
Disclosed Ownership
1,062,500 shares
Ownership
1.2%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 13:41:23 UTC
Date of event
13 Feb 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Rosalind Advisors, Inc. 1.2% 1,062,500 0 1,062,500 Steven Salamon President
SALAMON STEVEN A J 1.2% 1,062,500 0 1,062,500 Steven Salamon Steven Salamon
Aharon Gil 1.2% 1,062,500 0 1,062,500 Gil Aharon Gil Aharon
Rosalind Master Fund L.P. 1.2% 1,062,500 0 1,062,500 Mike McDonald Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)